These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2676618)

  • 21. [Relapses and indirect fluorescent antibody level in vivax malaria patients after chloroquine and chloroquine-primaquine treatment].
    Wang K; Liu YL; Zhang PN; Liu JX
    Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1984; 2(4):224-7. PubMed ID: 6394170
    [No Abstract]   [Full Text] [Related]  

  • 22. Malaria in New York City. IV. 1960-1971.
    Imperato PJ; Shookhoff HB; Harvey RP
    J Trop Med Hyg; 1974 Jan; 77(1):2-8. PubMed ID: 4590498
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevalence of malaria in Aligarh.
    Mehrunnisa A; Wajihullah ; Saifi MA; Khan HM
    J Commun Dis; 2002 Mar; 34(1):70-7. PubMed ID: 12718345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of an alternative scheme of treatment for the control of malaria].
    Méndez Galván JF; Guerrero Alvarado J; Gonález Mora M; Pérez Landa M; Quintero Cabanillas R
    Salud Publica Mex; 1984; 26(6):561-72. PubMed ID: 6393363
    [No Abstract]   [Full Text] [Related]  

  • 25. [Recurrent Plasmodium vivax malaria in spite of primaquine follow-up treatment].
    Telgt DS; Mulder L; Dolmans WM
    Ned Tijdschr Geneeskd; 1997 Sep; 141(37):1783-6. PubMed ID: 9545728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compliance to recommendations for the management of curative treatment of Plasmodium vivax/ovale infections.
    Faucher JF; Bellanger AP; Shaniya N; Hustache-Mathieu L; Hoen B; Chirouze C
    Med Mal Infect; 2014 Aug; 44(8):387-9. PubMed ID: 25015307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemotherapy and prophylaxis of malaria.
    Saint-Yves IF
    Med J Aust; 1973 Dec; 2(23):1052-4. PubMed ID: 4590861
    [No Abstract]   [Full Text] [Related]  

  • 28. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy.
    Goller JL; Jolley D; Ringwald P; Biggs BA
    Am J Trop Med Hyg; 2007 Feb; 76(2):203-7. PubMed ID: 17297026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tafenoquine for the treatment of recurrent Plasmodium vivax malaria.
    Kitchener S; Nasveld P; Edstein MD
    Am J Trop Med Hyg; 2007 Mar; 76(3):494-6. PubMed ID: 17360873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India.
    Dunne MW; Singh N; Shukla M; Valecha N; Bhattacharyya PC; Patel K; Mohapatra MK; Lakhani J; Devi CU; Adak T; Dev V; Yadav RS; Lele C; Patki K
    Am J Trop Med Hyg; 2005 Dec; 73(6):1108-11. PubMed ID: 16354821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of radical treatment on erythrocyte lipid peroxidation in Plasmodium vivax-infected malaria patients.
    Mathews ST; Selvam R
    Biochem Int; 1991 Sep; 25(2):211-20. PubMed ID: 1789788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seven patients with relapses of Plasmodium vivax or P. ovale despite primaquine treatment.
    Rombo L; Edwards G; Ward SA; Eriksson G; Lindquist L; Lindberg A; Runehagen A; Björkman A; Hylander NO
    Trop Med Parasitol; 1987 Mar; 38(1):49-50. PubMed ID: 3299660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relapse pattern of Plasmodium vivax in Mumbai: a study of 283 cases of vivax malaria.
    Gogtay NJ; Desai S; Kadam VS; Kamtekar KD; Dalvi SS; Kshirsagar NA
    J Assoc Physicians India; 2000 Nov; 48(11):1085-6. PubMed ID: 11310387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand.
    Walsh DS; Looareesuwan S; Wilairatana P; Heppner DG; Tang DB; Brewer TG; Chokejindachai W; Viriyavejakul P; Kyle DE; Milhous WK; Schuster BG; Horton J; Braitman DJ; Brueckner RP
    J Infect Dis; 1999 Oct; 180(4):1282-7. PubMed ID: 10479159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevention and treatment of malaria.
    Black RH
    Med J Aust; 1977 Jun; 1(25):929-33. PubMed ID: 329080
    [No Abstract]   [Full Text] [Related]  

  • 36. Low response of Colombian strains of Plasmodium vivax to classical antimalarial therapy.
    Arias AE; Corredor A
    Trop Med Parasitol; 1989 Mar; 40(1):21-3. PubMed ID: 2662351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Problems in the therapy for imported malaria in the United States.
    Singh K; Wester WC; Trenholme GM
    Arch Intern Med; 2003 Sep; 163(17):2027-30. PubMed ID: 14504115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental studies on the biological characteristics of Plasmodium vivax in south Yunnan].
    Yang BL; Wan WJ; Wang WR; Hu HX; Li HX; Li XL; Li CZ; Huang GZ
    Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1986; 4(2):101-5. PubMed ID: 3533306
    [No Abstract]   [Full Text] [Related]  

  • 39. Double-blind, randomized, placebo-controlled assessment of chloroquine/primaquine prophylaxis for malaria in nonimmune Colombian soldiers.
    Soto J; Toledo J; Rodriquez M; Sanchez J; Herrera R; Padilla J; Berman J
    Clin Infect Dis; 1999 Jul; 29(1):199-201. PubMed ID: 10433587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poor response to primaquine in two cases of Plasmodium vivax malaria from Guatemala.
    Gascon J; Gomez Arce JE; Menendez C; Valls ME; Corachán M
    Trop Geogr Med; 1994; 46(1):32-3. PubMed ID: 8165734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.